It has been over five years since the start of the GlaxoSmithKline case that rocked the China healthcare industry. At the time, compliance, audit and legal teams were shocked by the prevalence of integrity and corruption issues that had apparently gone unidentified, despite the widespread practice of generating slush funds through fraudulent travel expense claims.… Continue Reading
2018 was an eventful year in ISO 37001’s adoption journey. The anti-bribery standard’s flexibility was demonstrated through a variety of first-time (for ISO 37001) public and private sector uses.
The Brazilian and Danish prosecutors’ use of ISO 37001 in bribery settlement agreements, and the Korean Pharmaceutical and Bio-Pharma Manufacturers Association assistance to its 194 members with a phased ISO 37001 adoption approach, for example. … Continue Reading